Combining Neuropsychological Assessment with Neuroimaging to Distinguish Early-Stage Alzheimer’s Disease from Frontotemporal Lobar Degeneration in Non-Western Tonal Native Language-Speaking Individuals Living in Taiwan: A Case Series

Abstract

Neuropsychological tests (NPTs), which are routinely used in clinical practice for assessment of dementia, are also considered to be essential for differential diagnosis of Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD), especially the behavioral variants of frontotemporal dementia (bvFTD) and primary progressive aphasia (PPA) at their initial clinical presentations. However, the heterogeneous features of these diseases, which have many overlapping signs, make differentiation between AD and FTLD highly challenging. Moreover, NPTs were primarily developed in Western countries and for native speakers of non-tonal languages. Hence, there is an ongoing dispute over the validity and reliability of these tests in culturally different and typologically diverse language populations. The purpose of this case series was to examine which of the NPTs adjusted for Taiwanese society may be used to distinguish these two diseases. Since AD and FTLD have different effects on individuals’ brain, we combined NPTs with neuroimaging. We found that participants diagnosed with FTLD had lower scores in NPTs assessing language or social cognition than AD participants. PPA participants also had lower measures in the Free and Cued Selective Reminding Test than those diagnosed with bvFTD, while bvFTD participants showed poorer performances in the behavioral measures than PPA participants. In addition, the initial diagnosis was supported by the standard one-year clinical follow-up.

Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer’s disease

“…Recent studies have also shown a strong interest in integrating features from different neuroimaging modalities to predict neuropsychological assessments based on machine learning techniques ( Bhagwat et al, 2019 ; Tabarestani et al, 2020 ; Hojjati and Babajani-Feremi, 2022 ). Some studies have combined neuropsychological scores with neuroimaging biomarkers to find the progression trend or predict neuropsychological assessments ( Gill et al, 2020 ; Tabarestani et al, 2020 ; Kuo et al, 2023 ). However, the use of several predictors in such studies can result in the inclusion of unrelated information in their different prediction tasks, leading to a decrease in regression performance ( Zhou et al, 2012 ).…”

A LeViT–EfficientNet-Based Feature Fusion Technique for Alzheimer’s Disease Diagnosis

“…PET scans utilizing florbetapir, flutemetamol, or florbetaben may confirm AD [23]. Chin-Yun Kuo et al (2023) [24] discussed the significance of integrating neuropsychological assessment with neuroimaging in order to identify AD in its initial stages. Researchers can obtain valuable information on brain anatomical components from high-resolution MRI images.…”

Seeing Beyond the Symptoms: Biomarkers and Brain Regions Linked to Cognitive Decline in Alzheimer’s Disease

“…Recent studies have also shown a strong interest in integrating features from different neuroimaging modalities to predict neuropsychological assessments based on machine learning techniques [15,34]. Some studies have combined neuropsychological scores with neuroimaging biomarkers to find the progression trend or predict neuropsychological assessments [15,35,36]. However, the use of numerous predictors in such studies can lead to the inclusion of unrelated information in their different prediction tasks, leading to a decrease in regression performance [37].…”